A detailed history of Daiwa Securities Group Inc. transactions in United Therapeutics Corp stock. As of the latest transaction made, Daiwa Securities Group Inc. holds 4,119 shares of UTHR stock, worth $1.59 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
4,119
Previous 3,267 26.08%
Holding current value
$1.59 Million
Previous $1.04 Million 41.79%
% of portfolio
0.01%
Previous 0.01%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$311.04 - $363.55 $265,006 - $309,744
852 Added 26.08%
4,119 $1.48 Million
Q2 2024

Aug 07, 2024

SELL
$228.26 - $319.04 $93,586 - $130,806
-410 Reduced 11.15%
3,267 $1.04 Million
Q1 2024

May 02, 2024

BUY
$210.76 - $249.51 $102,218 - $121,012
485 Added 15.19%
3,677 $845,000
Q4 2023

Jan 31, 2024

BUY
$214.88 - $256.94 $26,430 - $31,603
123 Added 4.01%
3,192 $702,000
Q3 2023

Nov 01, 2023

BUY
$211.82 - $248.24 $21,182 - $24,824
100 Added 3.37%
3,069 $693,000
Q2 2023

Jul 31, 2023

SELL
$205.19 - $232.99 $2,872 - $3,261
-14 Reduced 0.47%
2,969 $655,000
Q1 2023

May 02, 2023

BUY
$212.99 - $276.17 $596,372 - $773,276
2,800 Added 1530.05%
2,983 $668,000
Q4 2022

Feb 06, 2023

BUY
$205.95 - $280.43 $2,883 - $3,926
14 Added 8.28%
183 $51,000
Q2 2022

Aug 09, 2022

BUY
$174.81 - $241.14 $6,642 - $9,163
38 Added 29.01%
169 $40,000
Q4 2021

Feb 03, 2022

SELL
$184.32 - $216.08 $4,239 - $4,969
-23 Reduced 14.94%
131 $28,000
Q3 2021

Nov 05, 2021

BUY
$179.86 - $214.88 $11,870 - $14,182
66 Added 75.0%
154 $28,000
Q1 2021

May 03, 2021

BUY
$153.94 - $174.85 $615 - $699
4 Added 4.76%
88 $15,000
Q4 2020

Feb 04, 2021

SELL
$101.87 - $151.79 $16,706 - $24,893
-164 Reduced 66.13%
84 $13,000
Q4 2019

Jan 31, 2020

SELL
$78.31 - $95.34 $2,349 - $2,860
-30 Reduced 10.79%
248 $22,000
Q2 2019

Jul 24, 2019

SELL
$76.06 - $120.81 $114,090 - $181,215
-1,500 Reduced 84.36%
278 $22,000
Q1 2019

Apr 26, 2019

SELL
$107.15 - $126.84 $2,250 - $2,663
-21 Reduced 1.17%
1,778 $209,000
Q4 2018

Feb 05, 2019

BUY
$101.4 - $128.73 $21,294 - $27,033
210 Added 13.22%
1,799 $196,000
Q1 2018

May 02, 2018

BUY
$107.21 - $151.94 $25,623 - $36,313
239 Added 17.7%
1,589 $179,000
Q3 2017

Nov 02, 2017

BUY
$114.6 - $136.81 $154,710 - $184,693
1,350
1,350 $158,000

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $17.6B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Daiwa Securities Group Inc. Portfolio

Follow Daiwa Securities Group Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Daiwa Securities Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Daiwa Securities Group Inc. with notifications on news.